| Josianne Bailey, MD, MBA | |
|
11234 Anderson St # Mc-1516, Loma Linda, CA 92354-2804 | |
| (909) 558-6491 | |
| Not Available |
| Full Name | Josianne Bailey |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 5 Years |
| Location | 11234 Anderson St # Mc-1516, Loma Linda, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033772546 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 180134 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loma Linda University Medical Center | Loma linda, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Faculty Physicians And Surgeons Of Llusm | 1153227814 | 1053 |
| Sac Health System | 4385533579 | 159 |
News Archive
A selection of health policy stories from New York, California, Virginia, South Carolina, Connecticut, Florida, Kansas, Minnesota, Michigan, Georgia and Colorado.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
A new study challenges the current staging system that determines the extent or severity of prostate cancer that has not metastasized. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study found that there is no link between localized prostate cancer's clinical stage and a patient's risk of cancer recurrence after having his prostate removed.
In a special issue of Human Mutation, a team including investigators at Brigham and Women's Hospital has announced the launch of the Matchmaker Exchange - a way for the rare disease community to share information and find new connections. Matchmaker Exchange connects databases of genetic information and symptoms that physicians and investigators can "match" with a patient's rare disease.
Ovulated egg cells, or oocytes, in adult female mice are not formed from germ cells in the blood or bone marrow.
› Verified 1 days ago
| Entity Name | Faculty Physicians And Surgeons Of Llusm |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205009917 PECOS PAC ID: 1153227814 Enrollment ID: O20031211000981 |
News Archive
A selection of health policy stories from New York, California, Virginia, South Carolina, Connecticut, Florida, Kansas, Minnesota, Michigan, Georgia and Colorado.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
A new study challenges the current staging system that determines the extent or severity of prostate cancer that has not metastasized. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study found that there is no link between localized prostate cancer's clinical stage and a patient's risk of cancer recurrence after having his prostate removed.
In a special issue of Human Mutation, a team including investigators at Brigham and Women's Hospital has announced the launch of the Matchmaker Exchange - a way for the rare disease community to share information and find new connections. Matchmaker Exchange connects databases of genetic information and symptoms that physicians and investigators can "match" with a patient's rare disease.
Ovulated egg cells, or oocytes, in adult female mice are not formed from germ cells in the blood or bone marrow.
› Verified 1 days ago
| Entity Name | Sac Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013935923 PECOS PAC ID: 4385533579 Enrollment ID: O20040315000608 |
News Archive
A selection of health policy stories from New York, California, Virginia, South Carolina, Connecticut, Florida, Kansas, Minnesota, Michigan, Georgia and Colorado.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
A new study challenges the current staging system that determines the extent or severity of prostate cancer that has not metastasized. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study found that there is no link between localized prostate cancer's clinical stage and a patient's risk of cancer recurrence after having his prostate removed.
In a special issue of Human Mutation, a team including investigators at Brigham and Women's Hospital has announced the launch of the Matchmaker Exchange - a way for the rare disease community to share information and find new connections. Matchmaker Exchange connects databases of genetic information and symptoms that physicians and investigators can "match" with a patient's rare disease.
Ovulated egg cells, or oocytes, in adult female mice are not formed from germ cells in the blood or bone marrow.
› Verified 1 days ago
| Entity Name | Faculty Physicians And Surgeons Of Llusm |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508255175 PECOS PAC ID: 1153227814 Enrollment ID: O20160216002196 |
News Archive
A selection of health policy stories from New York, California, Virginia, South Carolina, Connecticut, Florida, Kansas, Minnesota, Michigan, Georgia and Colorado.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
A new study challenges the current staging system that determines the extent or severity of prostate cancer that has not metastasized. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study found that there is no link between localized prostate cancer's clinical stage and a patient's risk of cancer recurrence after having his prostate removed.
In a special issue of Human Mutation, a team including investigators at Brigham and Women's Hospital has announced the launch of the Matchmaker Exchange - a way for the rare disease community to share information and find new connections. Matchmaker Exchange connects databases of genetic information and symptoms that physicians and investigators can "match" with a patient's rare disease.
Ovulated egg cells, or oocytes, in adult female mice are not formed from germ cells in the blood or bone marrow.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Josianne Bailey, MD, MBA 11234 Anderson St # Mc-1516, Loma Linda, CA 92354-2804 Ph: () - | Josianne Bailey, MD, MBA 11234 Anderson St # Mc-1516, Loma Linda, CA 92354-2804 Ph: (909) 558-6491 |
News Archive
A selection of health policy stories from New York, California, Virginia, South Carolina, Connecticut, Florida, Kansas, Minnesota, Michigan, Georgia and Colorado.
OxThera AB, a Stockholm-based privately-held biopharmaceutical company, today announced that it has initiated a clinical study in Primary Hyperoxaluria. This announcement bolsters the Company's position as a leader in developing therapies for hyperoxaluria, a debilitating condition that, if untreated, leads to kidney damage and end-stage renal disease.
A new study challenges the current staging system that determines the extent or severity of prostate cancer that has not metastasized. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study found that there is no link between localized prostate cancer's clinical stage and a patient's risk of cancer recurrence after having his prostate removed.
In a special issue of Human Mutation, a team including investigators at Brigham and Women's Hospital has announced the launch of the Matchmaker Exchange - a way for the rare disease community to share information and find new connections. Matchmaker Exchange connects databases of genetic information and symptoms that physicians and investigators can "match" with a patient's rare disease.
Ovulated egg cells, or oocytes, in adult female mice are not formed from germ cells in the blood or bone marrow.
› Verified 1 days ago
Petru Papacostea, Internal Medicine Medicare: Medicare Enrolled Practice Location: 11201 Benton St, Loma Linda, CA 92357 Phone: 909-825-7084 | |
Dr. Moosa Azadian, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11234 Anderson St, Loma Linda, CA 92354 Phone: 909-558-4085 | |
Douglas Wang, Internal Medicine Medicare: Medicare Enrolled Practice Location: 11234 Anderson Street, Gme Office Westerly Suite C, Loma Linda, CA 92354 Phone: 909-558-4174 | |
Dr. Lynnetta E Skoretz, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11201 Benton Street, #111h, Loma Linda, CA 92357 Phone: 909-825-7084 Fax: 909-777-3280 | |
Shahab Sean Shahangian, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 11234 Anderson St, Loma Linda, CA 92354 Phone: 818-532-8211 | |
Mst Nurjahan Khatun, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 11234 Anderson St # C, Loma Linda, CA 92354 Phone: 408-355-8650 | |
Snorri Olafsson, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 11370 Anderson St, Ste 3150, Loma Linda, CA 92354 Phone: 909-558-2191 |